Margaret A. Horn
Chief Operating OfficerMs. Margaret A. Horn, also known as Peg, J.D., serves as an Independent Director of Sangamo Therapeutics, Inc. since December 15, 2022. She is the Chief Operating Officer at Revolution Medicines, Inc. since October 2018. She served as General Counsel at Revolution Medicines, Inc. from December 2014 to September 2022 and served as its Senior Vice President of Corporate Development and as Executive Vice President from December 2014 to October 2018. Ms. Horn served as Senior Vice President of Legal & Corporate Development and General Counsel at Cogentus Pharmaceuticals, Inc. She also serves as Secretary of Revolution Medicines, Inc. She served as Senior Vice President of Legal and Corporate Development and General Counsel of Kosan Biosciences Incorporated from December 1, 2005 to August 24, 2007 and Secretary from January 2006 to August 24, 2007. She was Senior Vice President of Legal at Genencor International, Inc. Ms. Horn served as Chief Operating Officer at ProLynx Limited Liability Company from 2010 to December 2014. She has experience in the pharmaceutical and biotechnology industries. She served as Senior Vice President of Danisco US Inc. since June 2006. She served as General Counsel and Secretary of Danisco US Inc.'s since July 2004. She served as Co-General Counsel and Co-Secretary of Danisco US Inc. from June 15, 2004 to July 2004. She began her legal career at E.I. DuPont de Nemours & Company where she worked in DuPont's Pharmaceutical Division. After assisting in the implementation of the Pharmaceutical Joint Venture between DuPont and Merck in early 1991, she joined Danisco US Inc. While at Danisco US Inc., she has held various positions including General Patent Counsel and served as Vice President, Assistant General Counsel and Assistant Secretary. She is a member of the Pennsylvania and California bars and is a registered patent attorney with the U.S. Patent & Trademark Office. She is a registered pharmacist in Pennsylvania. Ms. Horn received her Bachelors of Science degree in Pharmacy from the Philadelphia College of Pharmacy and Science in 1985 followed by a Juries doctorate from Villanova Law School in 1988. She holds an executive M.B.A from the Pennsylvania State University.
Positions
- Company NameRevolution Medicines, Inc.Stock CodeRVMDPositionChief Operating OfficerRelated SecuritiesColleagues
- MAMark A. GoldsmithCEO, President & Chairman
- JAJack AndersChief Financial Officer
- JCJeffrey CisliniSenior VP, General Counsel & Corporate Secretary
- SMStephen M. KelseySenior Advisor
- MDMartin D. BurkeCo-Founder & Chairman of Scientific Advisory Board
- MAMichael A. FischbachAcademic Co-Founder & Member of Scientific Advisory Board
- KMKevan M. ShokatAcademic Co-Founder & Member of Scientific Advisory Board
- EMElizabeth McKee AndersonIndependent Director
